BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29038488)

  • 1. MCM2-regulated functional networks in lung cancer by multi-dimensional proteomic approach.
    Cheung CHY; Hsu CL; Chen KP; Chong ST; Wu CH; Huang HC; Juan HF
    Sci Rep; 2017 Oct; 7(1):13302. PubMed ID: 29038488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis.
    Cheng DD; Zhang HZ; Yuan JQ; Li SJ; Yang QC; Fan CY
    Oncotarget; 2017 Apr; 8(16):26380-26393. PubMed ID: 28460433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer.
    Yang J; Ramnath N; Moysich KB; Asch HL; Swede H; Alrawi SJ; Huberman J; Geradts J; Brooks JS; Tan D
    BMC Cancer; 2006 Aug; 6():203. PubMed ID: 16882345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conserved mechanism for coordinating replication fork helicase assembly with phosphorylation of the helicase.
    Bruck I; Kaplan DL
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11223-8. PubMed ID: 26305950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic Analysis and NIR-II Imaging of MCM2 Protein in Hepatocellular Carcinoma.
    Yang J; Xie Q; Zhou H; Chang L; Wei W; Wang Y; Li H; Deng Z; Xiao Y; Wu J; Xu P; Hong X
    J Proteome Res; 2018 Jul; 17(7):2428-2439. PubMed ID: 29750532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCM2 in human cancer: functions, mechanisms, and clinical significance.
    Sun Y; Cheng Z; Liu S
    Mol Med; 2022 Oct; 28(1):128. PubMed ID: 36303105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction between ATRIP and MCM complex is essential for ATRIP chromatin loading and its phosphorylation in mantle cell lymphoma cells.
    Nie Y; Lang T
    Pharmazie; 2017 Nov; 72(11):670-673. PubMed ID: 29442041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoproteome profile of human lung cancer cell line A549.
    Yu G; Xiao CL; Lu CH; Jia HT; Ge F; Wang W; Yin XF; Jia HL; He JX; He QY
    Mol Biosyst; 2011 Feb; 7(2):472-9. PubMed ID: 21060948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cancer stem cells by CXCL1, a chemokine whose secretion is controlled by MCM2.
    Kahm YJ; Kim IG; Kim RK
    BMC Cancer; 2024 Mar; 24(1):319. PubMed ID: 38454443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minichromosome Maintenance Complex is Required for Checkpoint Kinase 2 Chromatin Loading and its Phosphorylation to DNA Damage Response in SCC-4 Cells.
    Li L; Feng Y; Luo R
    Protein Pept Lett; 2017; 24(3):223-228. PubMed ID: 27964702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin.
    Deng M; Sun J; Xie S; Zhen H; Wang Y; Zhong A; Zhang H; Lu R; Guo L
    Mol Med Rep; 2019 Sep; 20(3):2258-2266. PubMed ID: 31322224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCM2 mediates progesterone-induced endometrial stromal cell proliferation and differentiation in mice.
    Kong S; Han X; Cui T; Zhou C; Jiang Y; Zhang H; Wang B; Wang H; Zhang S
    Endocrine; 2016 Aug; 53(2):595-606. PubMed ID: 26910396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 represses DNA replication initiation through antagonizing estrogen signaling and maintains genome stability in parallel with WEE1-MCM2 signaling during pregnancy.
    Xu X; Chen E; Mo L; Zhang L; Shao F; Miao K; Liu J; Su SM; Valecha M; Chan UI; Zheng H; Chen M; Chen W; Chen Q; Fu H; Aladjem MI; He Y; Deng CX
    Hum Mol Genet; 2019 Mar; 28(5):842-857. PubMed ID: 30445628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative mitochondrial proteomic analysis of human large cell lung cancer cell lines with different metastasis potential.
    Liu Z; Xu S; Li L; Zhong X; Chen C; Fan Y; Shen W; Zu L; Xue F; Wang M; Zhou Q
    Thorac Cancer; 2019 May; 10(5):1111-1128. PubMed ID: 30950202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.
    Zhang X; Teng Y; Yang F; Wang M; Hong X; Ye LG; Gao YN; Chen GY
    Oncol Rep; 2015 May; 33(5):2599-605. PubMed ID: 25738322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
    Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
    Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism.
    Dunn J; Ferluga S; Sharma V; Futschik M; Hilton DA; Adams CL; Lasonder E; Hanemann CO
    EBioMedicine; 2019 Feb; 40():77-91. PubMed ID: 30594554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients.
    Tang Z; Yang Y; Chen W; Li E; Liang T
    J Transl Med; 2022 Jan; 20(1):49. PubMed ID: 35093119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoro-Chromogenic Labelling for Detection of MCM2 to Assess Proliferation Activity in HER2-amplified Breast Carcinomas.
    Luhtala S; Haapaniemi T; Staff S; Isola J
    Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):175-186. PubMed ID: 30358612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.